Ramitra Biotech®
HomeAbout UsOur ProductsContact Us
Download Product Card
Back to Products
DICSOVIBE-MR - Diclofenac Potassium Paracetamol Chlorzoxazone tablet
Tablet

DICSOVIBE-MR

Diclofenac potassium (50 mg), Paracetamol (325 mg), Chlorzoxazone (250 mg)

Discover DICSOVIBE-MR, containing Diclofenac potassium (50 mg), Paracetamol (325 mg), Chlorzoxazone (250 mg), a premium WHO-GMP certified Tablet engineered by Ramitra Biotech in 10 x 10 Blister packing for optimal therapeutic efficacy and clinical safety standards.

📋 Specifications

Product NameDICSOVIBE-MR
CompositionDiclofenac potassium (50 mg), Paracetamol (325 mg), Chlorzoxazone (250 mg)
CategoryTablet
Packaging10 x 10 Blister
CertificationsWHO-GMP Certified / ISO 9001:2015 Approved
Franchise AvailabilityAvailable for PCD Franchise

Product Indications & Details

Potent triple-action formula combining Diclofenac potassium, Paracetamol, and Chlorzoxazone for comprehensive pain relief and muscle relaxation.
Effectively alleviates moderate to severe pain, inflammation, and muscle spasms associated with musculoskeletal conditions.
Rapid absorption and quick onset of action ensure fast-acting relief from discomfort and stiffness.
Designed for convenient oral administration in a 10 x 10 blister pack for ease of use and portability.
Ideal for managing conditions such as muscle strains, sprains, back pain, and post-operative discomfort.
Quantity

Related Formulations

DICSOVIBE-SP
Tablet

DICSOVIBE-SP

Tablet
DICSOVIBE-P
Tablet

DICSOVIBE-P

Tablet
Ramitra Biotech®

(Reliable And Modern Innovations in Therapeutic Research and Applications)

WHO-GMP certified pharmaceutical company delivering trusted formulations and PCD franchise opportunities across India.

WHO-GMP Certified
ISO Certified
GMP Certified
Home|About Us|Our Products|Contact Us|Testimonials||

© 2022 Ramitra Biotech. All rights reserved

|
Privacy Policy|Disclaimer
ACSOJIL-MR
Tablet

ACSOJIL-MR

Tablet
DICSOVIBE-AQ
Injection

DICSOVIBE-AQ

Injection